In Vitro and In Vivo Diagnostic Substances - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the In industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

In Vitro and In Vivo Diagnostic Substances - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - In Vitro and In Vivo Diagnostic Substances
Corporate Insider Buy Sell Ratio (Insider Count) - In Vitro and In Vivo Diagnostic Substances
In Vitro and In Vivo Diagnostic Substances - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date		 Security Form Insider Code 10b5-1 Direct Share
Price		 Shares
Changed
2025-09-21 MYGN / Myriad Genetics, Inc. 4 Ancona Margaret F - Taxes D 7.77 -958
2025-09-21 MYGN / Myriad Genetics, Inc. 4 Munk Natalie F - Taxes D 7.77 -962
2025-09-21 MYGN / Myriad Genetics, Inc. 4 Verratti Mark F - Taxes D 7.77 -1,085
2025-09-21 MYGN / Myriad Genetics, Inc. 4 Wheeler Benjamin Richard F - Taxes D 7.77 -2,559
2025-09-18 ACHV / Achieve Life Sciences, Inc. 4 Oki Mark K S - Sale D 2.92 -50,060
2025-09-18 ACHV / Achieve Life Sciences, Inc. 4 Stewart Richard Alistair S - Sale D 2.92 -129,501
2025-09-18 ACHV / Achieve Life Sciences, Inc. 4 Stewart Richard Alistair M - Exercise D 297,500
2025-09-18 ACHV / Achieve Life Sciences, Inc. 4 Oki Mark K M - Exercise D 168,000
2025-09-17 AWHL / Aspira Women's Health Inc. 4 Fraser John D P - Purchase D 0.45 16,389
2025-09-17 AWHL / Aspira Women's Health Inc. 4 SCHULER JACK W By Jack W. Schuler Living Trust P - Purchase I 0.45 1,111,111
2025-09-17 AWHL / Aspira Women's Health Inc. 4 cohen Jeffrey k By HealthView Asset Management P - Purchase I 0.45 55,556
2025-09-12 VNRX / VolitionRx Limited 4 Reynolds Cameron John P - Purchase D 0.659 15,000
2025-09-04 ACHV / Achieve Life Sciences, Inc. 4 JACOBS CINDY S - Sale D 2.77 -27,629
2025-09-04 ACHV / Achieve Life Sciences, Inc. 4 Xinos Jaime S - Sale D 2.77 -20,854
2025-09-04 ACHV / Achieve Life Sciences, Inc. 4 KING THOMAS BRAXTON S - Sale D 2.77 -139,858
2025-09-04 ACHV / Achieve Life Sciences, Inc. 4 Wann Jerry S - Sale D 2.77 -14,070
2025-09-04 ACHV / Achieve Life Sciences, Inc. 4 Wann Jerry M - Exercise D 34,100
2025-09-04 ACHV / Achieve Life Sciences, Inc. 4 KING THOMAS BRAXTON M - Exercise D 455,000
2025-09-04 ACHV / Achieve Life Sciences, Inc. 4 Xinos Jaime M - Exercise D 69,000
2025-09-04 ACHV / Achieve Life Sciences, Inc. 4 JACOBS CINDY M - Exercise D 110,000
2025-09-03 MYGN / Myriad Genetics, Inc. 4 Fox Jennifer Lynne F - Taxes D 6.80 -4,435
2025-09-01 IDXX / IDEXX Laboratories, Inc. 4 Smith Martin Alexander M - Exercise D 18
2025-09-01 IDXX / IDEXX Laboratories, Inc. 4 Smith Martin Alexander F - Taxes D 647.09 -5
2025-08-29 LNTH / Lantheus Holdings, Inc. 4 Marshall Robert J. Jr. F - Taxes D 54.90 -727
2025-08-22 IDXX / IDEXX Laboratories, Inc. 4 SZOSTAK M ANNE S - Sale D 647.3252 -2,187
2025-08-22 IDXX / IDEXX Laboratories, Inc. 4 SZOSTAK M ANNE M - Exercise D 206.62 2,187
2025-08-22 IDXX / IDEXX Laboratories, Inc. 4 SZOSTAK M ANNE Trust of M. Anne Szostak G - Gift I -259
2025-08-22 IDXX / IDEXX Laboratories, Inc. 4 SZOSTAK M ANNE The O'Hanian-Szostak Family Foundation G - Gift I 259
2025-08-20 LNTH / Lantheus Holdings, Inc. 4 FARALLON PARTNERS L L C/CA See Footnotes S - Sale I 56.15 -3,365,000
2025-08-20 LNTH / Lantheus Holdings, Inc. 4 PATEL RAJIV A See Footnotes S - Sale I 56.15 -3,365,000
2025-08-20 NTLA / Intellia Therapeutics, Inc. 4 CHASE WILLIAM J P - Purchase D 10.03 100,000
2025-08-19 LNTH / Lantheus Holdings, Inc. 4 PATEL RAJIV A See Footnotes S - Sale I 55.34 -41,000
2025-08-19 LNTH / Lantheus Holdings, Inc. 4 FARALLON PARTNERS L L C/CA See Footnotes S - Sale I 55.34 -41,000
2025-08-18 NEOG / Neogen Corporation 4 Naemura David H. M - Exercise D 5.43 14,294
2025-08-18 NEOG / Neogen Corporation 4 Jones Douglas Edward M - Exercise D 5.43 14,294
2025-08-18 NEOG / Neogen Corporation 4 ADENT JOHN EDWARD M - Exercise D 5.43 35,736
2025-08-18 NEOG / Neogen Corporation 4 Moylan John Patrick M - Exercise D 5.43 1,985
2025-08-18 NEOG / Neogen Corporation 4 Rocklin Amy M M - Exercise D 5.43 10,324
2025-08-18 NEOG / Neogen Corporation 4 Rocklin Amy M F - Taxes D 5.43 -3,005
2025-08-18 NEOG / Neogen Corporation 4 Moylan John Patrick F - Taxes D 5.43 -593
2025-08-18 NEOG / Neogen Corporation 4 Naemura David H. F - Taxes D 5.43 -5,947
2025-08-18 NEOG / Neogen Corporation 4 Jones Douglas Edward F - Taxes D 5.43 -4,160
2025-08-16 MYGN / Myriad Genetics, Inc. 4 Wheeler Benjamin Richard A - Award D 60,000
2025-08-15 IDXX / IDEXX Laboratories, Inc. 4 MAZELSKY JAY G - Gift D -1,051
2025-08-15 LNTH / Lantheus Holdings, Inc. 4 Brown Kimberly F - Taxes D 54.18 -463
2025-08-15 VNRX / VolitionRx Limited 4 Rootsaert Rodney Gerard A - Award D 15,223
2025-08-15 VNRX / VolitionRx Limited 4 Batchelor Ann-Louise A - Award D 27,400
2025-08-15 VNRX / VolitionRx Limited 4 Kway Jasmine A - Award D 12,507
2025-08-15 VNRX / VolitionRx Limited 4 Plummer Nicholas A - Award D 24,031
2025-08-15 VNRX / VolitionRx Limited 4 Nguyen Kim A - Award D 17,424
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)